EGFR and colorectal carcinoma: In the plasma cohort, we collected 89 pre-treatment plasma samples and 385 post-treatment plasma samples from CRC patients during continuous multiple courses anti-EGFR therapy in the plasma discovery cohort; and 31 pre-treatment plasma samples and 46 post-treatment plasma samples were collected in the plasma validation cohort.